文献速递免疫规划

第三代乙型肝炎表面抗原微针皮肤免疫研究

Skin immunization with third-generation hepatitis B surface antigen using microneedles.
PubMed 文献 · Vaccine · 2019-08-26

本研究将第三代乙型肝炎疫苗L-HBsAg不加佐剂通过微针进行皮内免疫,并与传统含氢氧化铝佐剂的肌内免疫比较。体外猪皮实验显示制剂在插入30分钟内溶解递送,含15%海藻糖的微针在40°C下稳定7天,冻融稳定性提高。28天时微针组抗体滴度高于传统肌内免疫组,提示无佐剂皮内递送L-HBsAg的可行性。

要点

  • L-HBsAg微针制剂位于针尖上三分之一,插入猪皮30分钟内溶解递送。
  • 含15%海藻糖的微针在40°C下稳定7天,冻融稳定性优于传统液体制剂。
  • 28天时微针组抗体滴度高于含氢氧化铝佐剂的传统肌内免疫组。

核心结论

  • L-HBsAg微针皮内免疫不加佐剂即可诱导高于传统含佐剂肌内免疫的28天抗体滴度。
  • 含海藻糖的微针制剂具有改善的热稳定性和冻融稳定性。

研究设计与样本

  • 研究将L-HBsAg包被于800微米长聚乳酸微针上,以猪皮进行体外递送实验。
  • 比较L-HBsAg微针皮内免疫与含氢氧化铝佐剂的L-HBsAg肌内免疫的抗体滴度。

主要发现

  • 制剂位于微针针尖上三分之一,插入猪皮30分钟内溶解并递送。
  • 海藻糖稳定效果随固化制剂中海藻糖含量增加而增强。
  • 含15%海藻糖的L-HBsAg微针在40°C下稳定7天,稳定性高于传统液体制剂。
  • L-HBsAg微针在冻融循环中稳定性改善。
  • 28天时L-HBsAg微针组抗体滴度高于含氢氧化铝佐剂的肌内免疫组。

临床怎么用

  • L-HBsAg微针皮内免疫可能无需佐剂即可实现有效递送,便于儿童疫苗接种。

局限性

  • 递送效率和给药时间仅通过体外猪皮实验确定。
  • 制剂对伽马射线灭菌的变性情况被观察,但摘要未报告具体结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

L-HBsAg is a third-generation hepatitis vaccine capable of inducing antibodies in non-responders and thus providing potentially therapeutic treatment. In this study, L-HBsAg was administered using microneedles (MN) without an adjuvant to induce intradermal (ID) immunization, and the efficacy of ID immunization was compared with that of intramuscular (IM) immunization that uses a conventional formulation with an adjuvant of aluminum hydroxide (L-HBsAg-AL-IM). The L-HBsAg was dip-coated onto 800-μm-long microneedles made of polylactic acid (PLA). Delivery efficiency and administration time were determined through in vitro experiments using porcine skin. The denaturation of the formulation against sterilization by gamma rays was observed. A storage test and a freeze-thaw cycle test of the microneedles with trehalose as a stabilizer (L-HBsAg-MN-Tre) were observed. An antibody titer of L-HBsAg-MN-Tre was compared with that of the conventional IM immunization of the L-HBsAg solution with aluminum hydroxide (L-HBsAg-AL-IM). The formulation containing L-HBsAg was located on the upper third of the microneedle tips. The formulation on the MN was dissolved and delivered within 30 min of insertion into porcine skin in vitro. Trehalose was selected as a stabilizer, and the stabilizing effect increased with the increase of trehalose content in the solidified formulation. L-HBsAg-MN with 15% of trehalose was stable for 7 days at 40 °C and showed increased stability compared to the conventional liquid formulations. L-HBsAg-MN-Tre showed improved stability during the freeze-thaw cycle. The antibody titer of L-HBsAg-MN-Tre at 28 days was higher than that of L-HBsAg-AL-IM. ID administration of L-HBsAg-MN-Tre showed better efficacy and improved thermal and freeze thaw stability compared to L-HBsAg-AL-IM. Therefore, L-HBsAg-MN-Tre administration showed the possibility of ID delivery of L-HBsAg without the use of an adjuvant for the efficacy, convenience, and safety of pediatric vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nguyen TT, Choi JA, Kim JS, et al. Skin immunization with third-generation hepatitis B surface antigen using microneedles. Vaccine. 2019. PMID: 31466705. doi:10.1016/j.vaccine.2019.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。